Second, to select genes with evidence of PTEN-SSL activity across multiple cell lines, we screened hits from the first screen combined with other previously reported PTEN-SSL candidate genes (~ 1200 genes total) in 11 genetically diverse breast cancer cell lines, of which 8 were PTEN-deficient. The gene discussed is PTEN; the disease is breast carcinoma.